DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,049,940 | -30.1% | 2,619,968 | 0.0% | 3.92% | +13.7% |
| Q2 2023 | $77,315,256 | +28.1% | 2,619,968 | 0.0% | 3.45% | +47.1% |
| Q1 2023 | $60,364,063 | -17.2% | 2,619,968 | 0.0% | 2.35% | +0.9% |
| Q4 2022 | $72,861,310 | -9.4% | 2,619,968 | 0.0% | 2.33% | -31.3% |
| Q3 2022 | $80,407,000 | +4.3% | 2,619,968 | 0.0% | 3.38% | +16.5% |
| Q2 2022 | $77,106,000 | -8.5% | 2,619,968 | 0.0% | 2.90% | +46.8% |
| Q1 2022 | $84,284,000 | -27.9% | 2,619,968 | 0.0% | 1.98% | +9.5% |
| Q4 2021 | $116,851,000 | -15.2% | 2,619,968 | -4.0% | 1.81% | +25.3% |
| Q3 2021 | $137,742,000 | -35.7% | 2,730,263 | 0.0% | 1.44% | -47.3% |
| Q2 2021 | $214,162,000 | +37.4% | 2,730,263 | 0.0% | 2.74% | +9.5% |
| Q1 2021 | $155,898,000 | -31.8% | 2,730,263 | 0.0% | 2.50% | -40.0% |
| Q4 2020 | $228,687,000 | +6.7% | 2,730,263 | -54.3% | 4.16% | -29.7% |
| Q3 2020 | $214,273,000 | +11.0% | 5,980,263 | -25.1% | 5.92% | +5.6% |
| Q2 2020 | $192,963,000 | +38.1% | 7,980,263 | 0.0% | 5.61% | -14.4% |
| Q1 2020 | $139,734,000 | +0.5% | 7,980,263 | 0.0% | 6.55% | -15.7% |
| Q4 2019 | $139,016,000 | +13.3% | 7,980,263 | -0.3% | 7.77% | +15.8% |
| Q3 2019 | $122,648,000 | -26.2% | 8,005,747 | 0.0% | 6.71% | -6.7% |
| Q2 2019 | $166,199,000 | -10.6% | 8,005,747 | 0.0% | 7.19% | +2.3% |
| Q1 2019 | $185,893,000 | +0.9% | 8,005,747 | -10.2% | 7.04% | -21.8% |
| Q4 2018 | $184,261,000 | -5.0% | 8,918,749 | 0.0% | 9.00% | -29.8% |
| Q3 2018 | $193,894,000 | +42.6% | 8,918,749 | 0.0% | 12.82% | -50.8% |
| Q2 2018 | $136,011,000 | -22.5% | 8,918,749 | 0.0% | 26.05% | -48.8% |
| Q1 2018 | $175,610,000 | +25.9% | 8,918,749 | 0.0% | 50.92% | +43.9% |
| Q4 2017 | $139,489,000 | – | 8,918,749 | – | 35.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |